Together, in this study, RASSF1, DAPK1 and ESR1 suggest utility of methylation markers to molecularly differentiate follicular thyroid cancer subtypes for enhanced classification. This evidence concerns the gene RASSF1 and thyroid gland follicular carcinoma.